Package 0597-0182-90

{"route": ["ORAL"], "spl_id": "16f275d5-7526-4e7a-8776-665a9a6ae37a", "openfda": {"nui": ["N0000187059", "N0000187058", "N0000175912", "N0000175913"], "unii": ["HDC1R2M35U", "3X29ZEJ4R2"], "rxcui": ["1602109", "1602115", "1602118", "1602120"], "spl_set_id": ["ddbab689-f76c-488c-9613-4168d41dd730"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0597-0182-30)", "package_ndc": "0597-0182-30", "marketing_start_date": "20150130"}, {"sample": false, "description": "30 BLISTER PACK in 1 CARTON (0597-0182-39)  / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0597-0182-39", "marketing_start_date": "20150130"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (0597-0182-90)", "package_ndc": "0597-0182-90", "marketing_start_date": "20150130"}], "brand_name": "Glyxambi", "product_id": "0597-0182_16f275d5-7526-4e7a-8776-665a9a6ae37a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Dipeptidyl Peptidase 4 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]", "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "0597-0182", "generic_name": "empagliflozin and linagliptin", "labeler_name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Glyxambi", "active_ingredients": [{"name": "EMPAGLIFLOZIN", "strength": "10 mg/1"}, {"name": "LINAGLIPTIN", "strength": "5 mg/1"}], "application_number": "NDA206073", "marketing_category": "NDA", "marketing_start_date": "20150130", "listing_expiration_date": "20271231"}